Abiopharma

Edgewise Therapeutics - Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers

Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)

Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology’s Kidney Week 2025